Medicare Enrolled
Dr. Lena Dumasia, MD
Hematology & Oncology · Lancaster, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dumasia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dumasia?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dumasia
Dr. Lena Dumasia is a hematology & oncology specialist in Lancaster, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dumasia performed 38,647 Medicare services across 3,092 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dumasia received a total of $9,285 from 82 pharmaceutical and/or device companies across 471 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dumasia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 13% volume in PA
$9,285 industry payments
Medicare Practice Summary
Medicare Utilization ↗38,647
Medicare services
Top 13% in PA for hematology & oncology
3,092
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,932 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
9,000 | $36 | $84 |
| Omalizumab injection (Xolair) for asthma/allergy | 6,090 | $30 | $60 |
| Denosumab injection (Prolia/Xgeva) | 4,320 | $18 | $39 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
4,308 | $6 | $16 |
| Injection, benralizumab, 1 mg | 1,590 | $132 | $285 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,556 | $0 | $0 |
| Iron infusion (Monoferric) | 1,300 | $17 | $43 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
969 | $7 | $7 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
906 | $8 | $15 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
698 | $11 | $40 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
637 | $10 | $19 |
| Glutamyltransferase (GGT) level test A blood test that measures the level of the liver enzyme glutamyltransferase (GGT) to help evaluate liver health. |
635 | $7 | $15 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
635 | $6 | $12 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
635 | $5 | $10 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
635 | $4 | $11 |
| Anti-nausea injection (Aloxi/palonosetron) | 620 | $1 | $7 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
524 | $92 | $150 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
520 | $3 | $7 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
325 | $22 | $45 |
| Injection, granisetron hydrochloride, 100 mcg | 240 | $0 | $1 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
212 | $98 | $213 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
204 | $1 | $2 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
194 | $47 | $118 |
| Pegfilgrastim-jmdb injection An injection of pegfilgrastim-jmdb, a biosimilar medication. The dose specified is 0.5 mg. |
192 | $98 | $330 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
187 | $12 | $40 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
148 | $16 | $38 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
144 | $55 | $102 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
140 | $13 | $26 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
124 | $10 | $40 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
106 | $1 | $3 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
99 | $22 | $50 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
77 | $1 | $2 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
59 | $19 | $35 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
59 | $7 | $13 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
54 | $49 | $120 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
46 | $1 | $7 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
45 | $16 | $33 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
42 | $9 | $18 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 39 | $20 | $42 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
36 | $29 | $75 |
| New patient office visit, complex (60-74 min) | 36 | $166 | $290 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
34 | $17 | $45 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
34 | $29 | $40 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
33 | $76 | $125 |
| Iron level test | 30 | $6 | $12 |
| Transferrin level test A blood test that measures the amount of transferrin, a protein that binds to and transports iron in the body. |
30 | $12 | $22 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
29 | $5 | $12 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
29 | $2 | $4 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $140 | $203 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
17 | $102 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
29.1% high complexity
54.2% medium
16.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,285
Total received (2018-2024)
Avg $1,326/year across 7 years
Top 23% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
82
Companies
471
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,833 (95.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$302 (3.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$150 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,247
2023
$1,868
2022
$1,423
2021
$976
2020
$636
2019
$904
2018
$1,231
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$209
PFIZER INC.
$178
AstraZeneca Pharmaceuticals LP
$159
Celgene Corporation
$143
Daiichi Sankyo Inc.
$141
E.R. Squibb & Sons, L.L.C.
$134
Takeda Pharmaceuticals U.S.A., Inc.
$122
Gilead Sciences, Inc.
$109
Incyte Corporation
$97
Bayer Healthcare Pharmaceuticals Inc.
$70
GlaxoSmithKline, LLC.
$64
ADC Therapeutics America, Inc.
$55
ABBVIE INC.
$55
Exelixis Inc.
$53
Merck Sharp & Dohme LLC
$51
Pharmacosmos Therapeutics Inc.
$51
JAZZ PHARMACEUTICALS INC.
$48
Ipsen Biopharmaceuticals, Inc
$47
Astellas Pharma US Inc
$45
PUMA BIOTECHNOLOGY, INC.
$42
TAIHO ONCOLOGY, INC.
$40
TerSera Therapeutics LLC
$39
EMD Serono, Inc.
$33
PROGENICS PHARMACEUTICALS, INC.
$29
Alexion Pharmaceuticals, Inc.
$27
Adaptive Biotechnologies Corporation
$26
Kyowa Kirin, Inc.
$24
Eisai Inc.
$24
ARRAY BIOPHARMA INC
$22
SOBI, INC
$21
Tempus AI, Inc
$18
BeiGene USA, Inc.
$18
Genentech USA, Inc.
$18
Sumitomo Pharma America, Inc.
$17
Aveo Pharmaceuticals, Inc.
$17
Top 3 companies account for 24.3% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$568
AstraZeneca Pharmaceuticals LP
$544
Novartis Pharmaceuticals Corporation
$516
Takeda Pharmaceuticals U.S.A., Inc.
$414
Janssen Biotech, Inc.
$393
PFIZER INC.
$350
Incyte Corporation
$307
Gilead Sciences, Inc.
$292
Daiichi Sankyo Inc.
$279
Pharmacyclics LLC, An AbbVie Company
$250
GENZYME CORPORATION
$245
Celgene Corporation
$245
Seagen Inc.
$204
Genentech USA, Inc.
$180
Lilly USA, LLC
$177
Astellas Pharma US Inc
$160
Servier Pharmaceuticals LLC
$159
Amgen Inc.
$157
COMSORT, Inc
$150
Merck Sharp & Dohme LLC
$144
TerSera Therapeutics LLC
$143
Merck Sharp & Dohme Corporation
$143
Alexion Pharmaceuticals, Inc.
$143
AbbVie Inc.
$138
Taiho Oncology, Inc.
$133
Ipsen Biopharmaceuticals, Inc
$121
Myovant Sciences Inc.
$118
Bayer HealthCare Pharmaceuticals Inc.
$110
Puma Biotechnology, Inc.
$107
Boehringer Ingelheim Pharmaceuticals, Inc.
$101
Pharmacosmos Therapeutics Inc.
$98
Exelixis Inc.
$90
BeiGene USA, Inc.
$90
Seattle Genetics, Inc.
$89
ADC Therapeutics America, Inc.
$83
MorphoSys, US Inc.
$83
EMD Serono, Inc.
$79
GlaxoSmithKline, LLC.
$77
Blueprint Medicines Corporation
$71
ABBVIE INC.
$70
Bayer Healthcare Pharmaceuticals Inc.
$70
JAZZ PHARMACEUTICALS INC.
$65
PUMA BIOTECHNOLOGY, INC.
$65
Kyowa Kirin, Inc.
$60
TAIHO ONCOLOGY, INC.
$60
Fresenius Kabi USA, LLC
$60
Janssen Pharmaceuticals, Inc
$59
AbbVie, Inc.
$57
AVEO Pharmaceuticals, Inc.
$53
Lexicon Pharmaceuticals, Inc.
$53
Regeneron Healthcare Solutions, Inc.
$50
Sandoz Inc.
$49
Rigel Pharmaceuticals, Inc.
$45
Eisai Inc.
$44
CTI BioPharma Corp.
$43
Teva Pharmaceuticals USA, Inc.
$43
Pharmacyclics LLC, an AbbVie Company
$37
Janssen Scientific Affairs, LLC
$36
Sumitomo Pharma America, Inc.
$35
Kite Pharma, Inc.
$33
Verastem, Inc.
$29
PROGENICS PHARMACEUTICALS, INC.
$29
Mylan Institutional Inc.
$28
Clovis Oncology, Inc.
$27
Adaptive Biotechnologies Corporation
$26
TESARO, Inc.
$25
G1 Therapeutics, Inc.
$25
Organon LLC
$24
ARRAY BIOPHARMA INC
$22
SOBI, INC
$21
Octapharma USA, Inc.
$20
EUSA Pharma (US) LLC
$19
EISAI INC.
$19
Tempus AI, Inc
$18
Aveo Pharmaceuticals, Inc.
$17
Agios Pharmaceuticals, Inc.
$17
Foundation Medicine, Inc.
$15
Deciphera Pharmaceuticals Inc.
$15
Sirtex Medical Inc
$14
Mirati Therapeutics, Inc.
$14
BTG International, Inc.
$14
McKesson Specialty Care Distribution, LLC
$11
Top 3 companies account for 17.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Avastin · BALVERSA · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · COSELA · CREON · CYRAMZA · Cabometyx · Columvi · Copiktra · Creon · DARZALEX · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Enhertu · Erleada · FASLODEX · FOTIVDA · FOUNDATIONONE · FRUZAQLA · FULPHILA · Fabhalta · GAUCHER-DISEASE · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · IMJUDO · INLYTA · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kabiven · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · Monoferric · NERLYNX · NINLARO · Nerlynx · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONTRUZANT · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYLARIFY · PYRUKYND · Padcev · Perjeta · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · Sodium Chloride · Somatuline Depot · Stivarga · Sylvant · TAFINLAR · TAGRISSO · TIBSOVO · TUKYSA · Tavalisse · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VORAXAZE · VOTRIENT · Venclexta · Vonjo · XALKORI · XARELTO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · ZARXIO · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
27
Per 100K population
4.9
County median income
$83,703
Nearest hospital
LANCASTER GENERAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dumasia is a mixed practice specialist, with above-average Medicare volume (top 13% in PA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dumasia experienced with immune globulin infusion (gammagard)?
Based on Medicare claims data, Dr. Dumasia performed 9,000 immune globulin infusion (gammagard) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dumasia receive payments from pharmaceutical companies?
Yes. Dr. Dumasia received a total of $9,285 from 82 companies across 471 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dumasia's costs compare to other hematology & oncology specialists in Lancaster?
Dr. Dumasia's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dumasia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Lancaster
Browse hematology & oncology specialists in Lancaster ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in PA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in PA
Which PA hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology